Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Arginine and proline metabolism	7/49	0.010484599803003085	1.0	0	0	2.8571428571428568	13.02242223966532	P4HA1;SMOX;CARNS1;CKB;ALDH18A1;CNDP1;AGMAT
Bladder cancer	6/41	0.01547935582050457	1.0	0	0	2.9268292682926824	12.19975031809441	MAP2K2;CCND1;MMP1;ERBB2;DAPK3;HRAS
Endometrial cancer	7/58	0.024986400078400667	1.0	0	0	2.413793103448276	8.90550523896042	CASP9;MAP2K2;CCND1;ERBB2;PIK3CD;GRB2;HRAS
Ether lipid metabolism	6/47	0.028763410125455306	1.0	0	0	2.553191489361702	9.060385994914286	PLA2G16;PLA2G2D;PLA2G2E;PLA2G2A;CHPT1;SELENOI
Phosphonate and phosphinate metabolism	2/6	0.032750693472061776	1.0	0	0	6.666666666666666	22.792207616037423	CHPT1;SELENOI
alpha-Linolenic acid metabolism	4/25	0.03399335307152362	1.0	0	0	3.1999999999999997	10.821088868398542	PLA2G16;PLA2G2D;PLA2G2E;PLA2G2A
Non-small cell lung cancer	7/66	0.0461316060876481	1.0	0	0	2.121212121212121	6.525393563105938	CASP9;MAP2K2;CCND1;ERBB2;PIK3CD;GRB2;HRAS
Hepatitis C	13/155	0.04729311576218661	1.0	0	0	1.6774193548387097	5.118461547976306	SCARB1;MAP2K2;STAT2;PIK3CD;EIF2AK4;TICAM1;CLDN6;CASP9;CCND1;IRF3;CLDN23;GRB2;HRAS
Glycerophospholipid metabolism	9/97	0.05352964797421329	1.0	0	0	1.8556701030927836	5.432510618038967	PLA2G16;PTDSS2;PLA2G2D;PLA2G2E;CHKA;PLA2G2A;CHPT1;LPIN2;SELENOI
Linoleic acid metabolism	4/29	0.05462119016329882	1.0	0	0	2.758620689655172	8.020229995291032	PLA2G16;PLA2G2D;PLA2G2E;PLA2G2A
Glutathione metabolism	6/56	0.059923284693461636	1.0	0	0	2.142857142857143	6.031478835629902	GSTM4;GSTM2;GPX4;MGST3;PGD;GSTM5
Prolactin signaling pathway	7/70	0.06002223966632419	1.0	0	0	2.0	5.626080248664981	SHC2;CCND2;MAP2K2;CCND1;PIK3CD;GRB2;HRAS
Pentose phosphate pathway	4/30	0.06063113352204076	1.0	0	0	2.6666666666666665	7.474524702251736	PFKL;TALDO1;PGD;ALDOA
HIF-1 signaling pathway	9/100	0.06260916608247201	1.0	0	0	1.7999999999999998	4.987518459393973	PFKL;MAP2K2;FLT1;NPPA;RPS6;ERBB2;PIK3CD;ALDOA;ENO3
B cell receptor signaling pathway	7/71	0.06385495665821075	1.0	0	0	1.9718309859154928	5.424785208031492	IFITM1;PPP3CB;CR2;MAP2K2;PIK3CD;GRB2;HRAS
Proteasome	5/45	0.07270586423397986	1.0	0	0	2.222222222222222	5.825184964955028	PSMB5;PSMD4;PSMA1;PSMD13;PSMB10
VEGF signaling pathway	6/59	0.073523209939382	1.0	0	0	2.0338983050847457	5.308788083641293	CASP9;PPP3CB;SHC2;MAP2K2;PIK3CD;HRAS
Hepatocellular carcinoma	13/168	0.07879351956271097	1.0	0	0	1.5476190476190477	3.932383192759065	FZD1;GSTM4;SHC2;GSTM2;MAP2K2;MGST3;PIK3CD;SMARCA2;SMARCA4;CCND1;GRB2;HRAS;GSTM5
Base excision repair	4/33	0.08064706826013496	1.0	0	0	2.4242424242424243	6.103449276278521	POLD4;FEN1;POLD2;NEIL1
Fructose and mannose metabolism	4/33	0.08064706826013496	1.0	0	0	2.4242424242424243	6.103449276278521	GMPPB;PFKL;ENOSF1;ALDOA
Hedgehog signaling pathway	5/47	0.08428928588938157	1.0	0	0	2.127659574468085	5.26276705761003	CCND2;CCND1;BTRC;KIF7;CSNK1G2
Rap1 signaling pathway	15/206	0.09337267400518723	1.0	0	0	1.4563106796116503	3.4531406011045145	MAP2K2;FLT1;PIK3CD;ARAP3;FGF3;RAP1GAP;EFNA3;ADCY9;SIPA1L1;ADORA2B;FGF18;PFN1;HRAS;BCAR1;EPHA2
Arachidonic acid metabolism	6/63	0.09416438282354153	1.0	0	0	1.9047619047619047	4.500406229636559	PLA2G16;PLA2G2D;PLA2G2E;ALOX5;PTGES3;PLA2G2A
Complement and coagulation cascades	7/79	0.0997335943841466	1.0	0	0	1.7721518987341771	4.085257956571327	CR2;CR1;C1S;C5AR1;CD59;F2;SERPINA5
Vibrio cholerae infection	5/50	0.10336068197068972	1.0	0	0	2.0	4.5390612819119465	ERO1A;TJP1;ADCY9;ATP6V1E1;ATP6V1E2
Central carbon metabolism in cancer	6/65	0.10553500656937817	1.0	0	0	1.8461538461538463	4.1514693512884095	PFKL;MAP2K2;GLS2;ERBB2;PIK3CD;HRAS
Aldosterone-regulated sodium reabsorption	4/37	0.11170784333278796	1.0	0	0	2.1621621621621623	4.739174827095357	SLC9A3R2;ATP1A4;PIK3CD;SFN
Breast cancer	11/147	0.11883496557521814	1.0	0	0	1.4965986394557822	3.1877844239018156	FZD1;SHC2;MAP2K2;CCND1;SP1;FGF18;ERBB2;PIK3CD;GRB2;HRAS;FGF3
Choline metabolism in cancer	8/99	0.12224070691787418	1.0	0	0	1.6161616161616161	3.3967889625023044	MAP2K2;CHKA;SP1;PIK3CD;GRB2;CHPT1;PIP5K1C;HRAS
Epstein-Barr virus infection	14/201	0.13245593593097613	1.0	0	0	1.3930348258706466	2.816027210973453	ENTPD1;USP7;CR2;PSMD13;STAT2;PIK3CD;ISG15;CASP9;HLA-DMA;CCND2;PSMD4;CCND1;IRF3;MAP3K14
Non-homologous end-joining	2/13	0.13537899404817505	1.0	0	0	3.076923076923077	6.1528525246417765	FEN1;DNTT
Regulation of lipolysis in adipocytes	5/55	0.13937991022954382	1.0	0	0	1.8181818181818181	3.582821649166955	PLA2G16;ADCY9;NPPA;PIK3CD;ABHD5
Fat digestion and absorption	4/41	0.14721479282726987	1.0	0	0	1.951219512195122	3.7382684546071134	SCARB1;PLA2G2D;PLA2G2E;PLA2G2A
Calcium signaling pathway	13/188	0.14867924364464086	1.0	0	0	1.3829787234042552	2.63590768820473	RYR1;PTAFR;ATP2B4;P2RX7;SLC8A3;PPP3CB;CYSLTR2;ADCY9;GNAL;STIM1;ADORA2B;ERBB2;PHKG2
Melanoma	6/72	0.15049803689681743	1.0	0	0	1.6666666666666665	3.1563420645887432	MAP2K2;CCND1;FGF18;PIK3CD;HRAS;FGF3
Pyrimidine metabolism	5/57	0.15514033768438892	1.0	0	0	1.7543859649122806	3.2691669601382802	ENTPD1;UCK2;CANT1;TK2;DCTPP1
Rheumatoid arthritis	7/91	0.17003916876293382	1.0	0	0	1.5384615384615385	2.725733021512411	HLA-DMA;FLT1;MMP1;CTSK;LTB;ATP6V1E1;ATP6V1E2
Glioma	6/75	0.17201595491043623	1.0	0	0	1.5999999999999999	2.8162688725816674	SHC2;MAP2K2;CCND1;PIK3CD;GRB2;HRAS
Chronic myeloid leukemia	6/76	0.17945756311992533	1.0	0	0	1.5789473684210524	2.712341867627267	SHC2;MAP2K2;CCND1;PIK3CD;GRB2;HRAS
Focal adhesion	13/199	0.1977326935793627	1.0	0	0	1.306532663316583	2.1176793474158924	SHC2;FLT1;PIK3CD;PARVA;MYL12B;CCND2;CCND1;ERBB2;GRB2;PIP5K1C;HRAS;BIRC2;BCAR1
beta-Alanine metabolism	3/31	0.20065196718317338	1.0	0	0	1.9354838709677418	3.1087420224475646	SMOX;CARNS1;CNDP1
Human T-cell leukemia virus 1 infection	14/219	0.20813525593007634	1.0	0	0	1.278538812785388	2.0067525099609127	CRTC2;RANBP3;MAP2K2;NFYB;PIK3CD;ELK4;PPP3CB;HLA-DMA;ADCY9;CCND2;CCND1;TCF3;HRAS;MAP3K14
Prostate cancer	7/97	0.21155364258994297	1.0	0	0	1.4432989690721647	2.241842635816865	CASP9;MAP2K2;CCND1;ERBB2;PIK3CD;GRB2;HRAS
Gastric cancer	10/149	0.21263497715518503	1.0	0	0	1.3422818791946307	2.0780916854371307	FZD1;SHC2;MAP2K2;CCND1;FGF18;ERBB2;PIK3CD;GRB2;HRAS;FGF3
Cortisol synthesis and secretion	5/65	0.2245509341987312	1.0	0	0	1.5384615384615385	2.2979272602185437	NR5A1;SCARB1;ADCY9;SP1;PBX1
D-Glutamine and D-glutamate metabolism	1/5	0.22623900494711593	1.0	0	0	4.0	5.9446531780071785	GLS2
Acute myeloid leukemia	5/66	0.23381942521025603	1.0	0	0	1.5151515151515151	2.201827497975576	MAP2K2;CCND1;PIK3CD;GRB2;HRAS
Chemokine signaling pathway	12/190	0.24303237414729376	1.0	0	0	1.263157894736842	1.786813411669786	GRK1;HCK;SHC2;ADCY9;CCL7;STAT2;CCL4;PIK3CD;GRB2;CCL18;HRAS;BCAR1
ErbB signaling pathway	6/85	0.2515228769093023	1.0	0	0	1.4117647058823528	1.9485477624185077	SHC2;MAP2K2;ERBB2;PIK3CD;GRB2;HRAS
Fc epsilon RI signaling pathway	5/68	0.25266492029805	1.0	0	0	1.4705882352941175	2.023075137913094	MAP2K2;ALOX5;PIK3CD;GRB2;HRAS
Staphylococcus aureus infection	5/68	0.25266492029805	1.0	0	0	1.4705882352941175	2.023075137913094	HLA-DMA;C1S;C5AR1;PTAFR;FCGR2C
Alanine, aspartate and glutamate metabolism	3/35	0.25416276879858296	1.0	0	0	1.7142857142857142	2.3481949631326344	ALDH5A1;GLS2;RIMKLA
Colorectal cancer	6/86	0.25999953625691774	1.0	0	0	1.3953488372093021	1.8796401371099152	CASP9;MAP2K2;CCND1;PIK3CD;GRB2;HRAS
Thermogenesis	14/231	0.2672701409403699	1.0	0	0	1.2121212121212122	1.5993883251494772	COX8A;NDUFA11;NDUFB10;RPS6;BMP8A;NDUFB1;SMARCA2;SMARCA4;ADCY9;NPPA;ZNF516;GRB2;NDUFV2;HRAS
DNA replication	3/36	0.2678594070249647	1.0	0	0	1.6666666666666665	2.1954883946257717	POLD4;FEN1;POLD2
Ras signaling pathway	14/232	0.27245022153486487	1.0	0	0	1.206896551724138	1.5693268075560824	SHC2;PLA2G2D;MAP2K2;FLT1;PLA2G2E;PLA2G2A;PIK3CD;FGF3;PLA2G16;EFNA3;FGF18;GRB2;HRAS;EPHA2
Gap junction	6/88	0.2771694338705115	1.0	0	0	1.3636363636363635	1.7497176615936614	TJP1;TUBB6;MAP2K2;ADCY9;GRB2;HRAS
Thyroid cancer	3/37	0.2816374857336128	1.0	0	0	1.6216216216216217	2.054812778279635	MAP2K2;CCND1;HRAS
Apoptosis	9/143	0.28725766333695896	1.0	0	0	1.2587412587412588	1.5701232390111806	CASP9;MAP2K2;CTSK;PIK3CD;MAP3K14;HRAS;LMNB2;BIRC2;MCL1
Adherens junction	5/72	0.2913681345785638	1.0	0	0	1.3888888888888888	1.712732977852415	TJP1;PTPRB;ERBB2;PTPRM;SSX2IP
JAK-STAT signaling pathway	10/162	0.29239705812910793	1.0	0	0	1.2345679012345678	1.518077299105048	CCND2;IL20;CCND1;STAT2;PIK3CD;GRB2;IL17D;HRAS;IL27RA;MCL1
Metabolism of xenobiotics by cytochrome P450	5/74	0.31110059336369467	1.0	0	0	1.3513513513513513	1.577890496988918	GSTM4;GSTM2;AKR7A3;MGST3;GSTM5
Histidine metabolism	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	CARNS1;CNDP1
Mannose type O-glycan biosynthesis	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	B3GAT1;LARGE2
Mismatch repair	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	POLD4;POLD2
Proximal tubule bicarbonate reclamation	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	GLS2;ATP1A4
Relaxin signaling pathway	8/130	0.32503810276627726	1.0	0	0	1.2307692307692308	1.3831542944535802	SHC2;MAP2K2;ADCY9;MMP1;RLN3;PIK3CD;GRB2;HRAS
Homologous recombination	3/41	0.3371468638537048	1.0	0	0	1.4634146341463412	1.5910780182096236	POLD4;BLM;POLD2
Tight junction	10/170	0.34499465048375516	1.0	0	0	1.176470588235294	1.2520310210766845	CLDN6;TJP1;CCND1;CLDN23;ERBB2;LLGL1;TJP3;MYL12B;RAB8B;CRB3
Hematopoietic cell lineage	6/97	0.3569285827398046	1.0	0	0	1.2371134020618557	1.2744984316239885	CD2;CR2;HLA-DMA;CR1;DNTT;CD59
Thyroid hormone signaling pathway	7/116	0.3606196265526343	1.0	0	0	1.206896551724138	1.2309518612816097	CASP9;MAP2K2;THRB;CCND1;ATP1A4;PIK3CD;HRAS
Aldosterone synthesis and secretion	6/98	0.3659360545830404	1.0	0	0	1.2244897959183672	1.2309755205294757	SCARB1;ADCY9;NPPA;ATP1A4;ATP2B4;DAGLB
Pancreatic secretion	6/98	0.3659360545830404	1.0	0	0	1.2244897959183672	1.2309755205294757	PLA2G2D;ADCY9;PLA2G2E;PLA2G2A;ATP1A4;ATP2B4
Huntington disease	11/193	0.3718538023335192	1.0	0	0	1.1398963730569949	1.1276476239158606	COX8A;CASP9;NDUFA11;NDUFB10;SP1;AP2S1;POLR2E;NDUFB1;NDUFV2;RCOR1;POLR2L
Maturity onset diabetes of the young	2/26	0.3759320092394212	1.0	0	0	1.5384615384615385	1.5051491975911149	NR5A2;HNF1A
Apelin signaling pathway	8/137	0.3782278714972952	1.0	0	0	1.167883211678832	1.1354842982136466	RYR1;SLC8A3;HDAC5;MAP2K2;ADCY9;CCND1;RPS6;HRAS
Regulation of actin cytoskeleton	12/214	0.3837832938711756	1.0	0	0	1.1214953271028036	1.074030532228796	ENAH;MAP2K2;FGF18;PIK3CD;PIP5K1C;PFN1;F2;HRAS;SSH3;FGF3;BCAR1;MYL12B
Cytosolic DNA-sensing pathway	4/63	0.38719146599357773	1.0	0	0	1.2698412698412698	1.204871065559935	IRF3;CCL4;POLR2E;POLR2L
Chemical carcinogenesis	5/82	0.39117601725719064	1.0	0	0	1.2195121951219512	1.1446312783908745	SULT1A1;GSTM4;GSTM2;MGST3;GSTM5
T cell receptor signaling pathway	6/101	0.39300017337866283	1.0	0	0	1.188118811881188	1.109637892212941	PPP3CB;MAP2K2;PIK3CD;GRB2;MAP3K14;HRAS
Signaling pathways regulating pluripotency of stem cells	8/139	0.39355473032009886	1.0	0	0	1.1510791366906474	1.0734217379560849	FZD1;MAP2K2;SMAD9;PIK3CD;GRB2;HNF1A;TCF3;HRAS
Collecting duct acid secretion	2/27	0.39397603610044213	1.0	0	0	1.4814814814814814	1.3799484349837585	ATP6V1E1;ATP6V1E2
Synthesis and degradation of ketone bodies	1/10	0.40133341390034794	1.0	0	0	2.0	1.8259254820662505	OXCT2
MAPK signaling pathway	16/295	0.40539466480088415	1.0	0	0	1.0847457627118644	0.979410663467526	MAP2K2;FLT1;MAX;ECSIT;FGF3;ELK4;PPP3CB;EFNA3;FGF18;ERBB2;GRB2;MAPT;HRAS;MAP3K14;EPHA2;MAP4K4
Hippo signaling pathway	9/160	0.4073910770526227	1.0	0	0	1.125	1.0102293873083648	FZD1;TEAD4;CCND2;CCND1;BMP8A;DCHS1;BTRC;LLGL1;BIRC2
Butanoate metabolism	2/28	0.4117777723443979	1.0	0	0	1.4285714285714284	1.2675306609542623	ALDH5A1;OXCT2
Parkinson disease	8/142	0.41656279001234714	1.0	0	0	1.1267605633802817	0.9867245886261043	CASP9;COX8A;GNAL;NDUFA11;NDUFB10;NDUFB1;UBE2J2;NDUFV2
C-type lectin receptor signaling pathway	6/104	0.4200266801120024	1.0	0	0	1.1538461538461537	1.0008888988224178	PPP3CB;STAT2;PIK3CD;IL17D;MAP3K14;HRAS
Toll-like receptor signaling pathway	6/104	0.4200266801120024	1.0	0	0	1.1538461538461537	1.0008888988224178	MAP2K2;IRF3;CTSK;CCL4;PIK3CD;TICAM1
Salmonella infection	5/86	0.4311336138274714	1.0	0	0	1.1627906976744184	0.9782991023729873	TJP1;CCL4;PLEKHM2;PKN2;PFN1
Taurine and hypotaurine metabolism	1/11	0.43128166280518815	1.0	0	0	1.8181818181818181	1.529079804244035	CDO1
Endocrine and other factor-regulated calcium reabsorption	3/48	0.43306631871249	1.0	0	0	1.25	1.0460805021359667	ADCY9;ATP1A4;AP2S1
Epithelial cell signaling in Helicobacter pylori infection	4/68	0.44400267624141365	1.0	0	0	1.176470588235294	0.9552055164674429	TJP1;ATP6V1E1;ATP6V1E2;MAP3K14
Ovarian steroidogenesis	3/49	0.44640402063272916	1.0	0	0	1.2244897959183672	0.987588809585937	SCARB1;ADCY9;ALOX5
Osteoclast differentiation	7/127	0.45129692526290477	1.0	0	0	1.1023622047244093	0.8770722042008007	PPP3CB;CTSK;STAT2;PIK3CD;GRB2;MAP3K14;FCGR2C
Human cytomegalovirus infection	12/225	0.4514330940391003	1.0	0	0	1.0666666666666667	0.8483499766033407	CASP9;PPP3CB;ADCY9;MAP2K2;CCND1;IRF3;SP1;CCL4;PIK3CD;GRB2;HRAS;BCAR1
Kaposi sarcoma-associated herpesvirus infection	10/186	0.453202580319	1.0	0	0	1.075268817204301	0.8509850067631957	CASP9;HCK;PPP3CB;MAP2K2;CCND1;IRF3;STAT2;PIK3CD;TICAM1;HRAS
Transcriptional misregulation in cancer	10/186	0.453202580319	1.0	0	0	1.075268817204301	0.8509850067631957	ELK4;CCND2;FLT1;MAX;SP1;LMO2;TCF3;HIST2H3D;MLLT3;PBX1
Renal cell carcinoma	4/69	0.45518892642326336	1.0	0	0	1.1594202898550725	0.9125133023815558	MAP2K2;PIK3CD;GRB2;HRAS
Drug metabolism	6/108	0.45579415117862115	1.0	0	0	1.111111111111111	0.8730155491595808	GSTM4;GSTM2;UCK2;MGST3;TK2;GSTM5
Autophagy	7/128	0.45946687100202477	1.0	0	0	1.09375	0.8505967287493645	MAP2K2;TP53INP2;DAPK3;ATG4C;PIK3CD;EIF2AK4;HRAS
Phospholipase D signaling pathway	8/148	0.46236222561490486	1.0	0	0	1.0810810810810811	0.8339531426705211	SHC2;MAP2K2;ADCY9;PIK3CD;GRB2;PIP5K1C;F2;HRAS
Galactose metabolism	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	GALE;PFKL
Mucin type O-glycan biosynthesis	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	GALNT16;B4GALT5
RNA polymerase	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	POLR2E;POLR2L
Mineral absorption	3/51	0.47268752481329424	1.0	0	0	1.176470588235294	0.881553803378603	ATP1A4;MT1H;MT1B
Human papillomavirus infection	17/330	0.4851528081345037	1.0	0	0	1.0303030303030303	0.7452092896330131	FZD1;MAP2K2;STAT2;PIK3CD;ISG15;TICAM1;CCND2;CCND1;IRF3;NFX1;GRB2;ATP6V1E1;ATP6V1E2;HRAS;HES2;LLGL1;CRB3
Bile secretion	4/72	0.48826565745953704	1.0	0	0	1.111111111111111	0.7965507124555724	SCARB1;ADCY9;AQP8;ATP1A4
p53 signaling pathway	4/72	0.48826565745953704	1.0	0	0	1.111111111111111	0.7965507124555724	CASP9;CCND2;CCND1;SFN
FoxO signaling pathway	7/132	0.49185149962456454	1.0	0	0	1.0606060606060606	0.7525831919041477	USP7;CCND2;MAP2K2;CCND1;PIK3CD;GRB2;HRAS
Vascular smooth muscle contraction	7/132	0.49185149962456454	1.0	0	0	1.0606060606060606	0.7525831919041477	PLA2G2D;MAP2K2;ADCY9;PLA2G2E;ADORA2B;NPPA;PLA2G2A
mTOR signaling pathway	8/152	0.49250496644326186	1.0	0	0	1.0526315789473684	0.7455270887074559	FZD1;MAP2K2;RPS6;PIK3CD;GRB2;ATP6V1E1;ATP6V1E2;HRAS
Small cell lung cancer	5/93	0.4994819883860412	1.0	0	0	1.075268817204301	0.7464341299256831	CASP9;CCND1;MAX;PIK3CD;BIRC2
Oxidative phosphorylation	7/133	0.49985934680088157	1.0	0	0	1.0526315789473684	0.7299247647707883	COX8A;NDUFA11;NDUFB10;NDUFB1;ATP6V1E1;NDUFV2;ATP6V1E2
Oxytocin signaling pathway	8/153	0.49996933200782423	1.0	0	0	1.0457516339869282	0.7249239408370461	RYR1;PPP3CB;MAP2K2;ADCY9;EEF2K;CCND1;NPPA;HRAS
Ribosome	8/153	0.49996933200782423	1.0	0	0	1.0457516339869282	0.7249239408370461	MRPL20;RPL41;RNA5S12;RPS6;RPLP2;MRPS21;MRPL9;FAU
Bacterial invasion of epithelial cells	4/74	0.5098528753630284	1.0	0	0	1.0810810810810811	0.7282519724998587	SHC2;PIK3CD;ELMO3;BCAR1
Inositol phosphate metabolism	4/74	0.5098528753630284	1.0	0	0	1.0810810810810811	0.7282519724998587	IMPA2;PIK3CD;PIP5K1C;PLCH2
Cushing syndrome	8/155	0.5147966059985056	1.0	0	0	1.032258064516129	0.6854022153666004	FZD1;NR5A1;SCARB1;MAP2K2;ADCY9;CCND1;SP1;PBX1
NF-kappa B signaling pathway	5/95	0.5184489993734346	1.0	0	0	1.0526315789473684	0.6914880189626921	CCL4;LTB;TICAM1;MAP3K14;BIRC2
Pancreatic cancer	4/75	0.520490485053102	1.0	0	0	1.0666666666666667	0.6965159162578138	CASP9;CCND1;ERBB2;PIK3CD
Pertussis	4/76	0.531017425175643	1.0	0	0	1.0526315789473684	0.666274150005563	IRF3;C1S;SFTPA1;TICAM1
Estrogen signaling pathway	7/137	0.5314567341654012	1.0	0	0	1.021897810218978	0.645975826925556	SHC2;MAP2K2;ADCY9;SP1;PIK3CD;GRB2;HRAS
Insulin signaling pathway	7/137	0.5314567341654012	1.0	0	0	1.021897810218978	0.645975826925556	SHC2;MAP2K2;RPS6;PHKG2;PIK3CD;GRB2;HRAS
Wnt signaling pathway	8/158	0.5367521851002154	1.0	0	0	1.0126582278481011	0.6300949582261924	FZD1;VANGL1;PPP3CB;CCND2;CCND1;DAAM1;BTRC;LGR4
Measles	7/138	0.5392352041131376	1.0	0	0	1.0144927536231885	0.6265542063646131	CASP9;CCND2;CCND1;IRF3;STAT2;PIK3CD;EIF2AK4
Cellular senescence	8/160	0.5511758519618988	1.0	0	0	1.0	0.5957013701808717	PPP3CB;CCND2;MAP2K2;CCND1;HUS1;PIK3CD;BTRC;HRAS
Viral carcinogenesis	10/201	0.5523179780186385	1.0	0	0	0.9950248756218906	0.5906779616132228	HDAC5;USP7;CCND2;CCND1;IRF3;HIST1H2BI;PIK3CD;GRB2;HIST1H2BB;HRAS
Axon guidance	9/181	0.555066973103549	1.0	0	0	0.9944751381215469	0.5854141991509727	ENAH;SEMA4A;EFNA3;PPP3CB;PIK3CD;SSH3;HRAS;EPHA2;MYL12B
AMPK signaling pathway	6/120	0.558921512029944	1.0	0	0	1.0	0.5817462235027698	CRTC2;PFKL;EEF2K;CCND1;PIK3CD;ADIPOR2
RNA degradation	4/79	0.561890006637219	1.0	0	0	1.0126582278481011	0.5837459908567373	PAN2;PFKL;WDR61;ENO3
Endocytosis	12/244	0.5653591438681038	1.0	0	0	0.9836065573770492	0.5609450133575461	EHD1;GRK1;EHD2;GIT2;RAB31;AP2S1;VPS37D;ARAP3;AMPH;PIP5K1C;RAB11FIP3;HRAS
Viral myocarditis	3/59	0.5713815260202666	1.0	0	0	1.0169491525423728	0.5691845296161483	CASP9;HLA-DMA;CCND1
Hepatitis B	8/163	0.5724547815603112	1.0	0	0	0.9815950920245399	0.5475548769053109	CASP9;MAP2K2;IRF3;STAT2;PIK3CD;GRB2;TICAM1;HRAS
Melanogenesis	5/101	0.5733754172932677	1.0	0	0	0.9900990099009901	0.5507075230503586	FZD1;MAP2K2;ADCY9;MC1R;HRAS
Long-term depression	3/60	0.5828910435264506	1.0	0	0	1.0	0.5397549994176116	RYR1;MAP2K2;HRAS
Glucagon signaling pathway	5/103	0.5909417872320486	1.0	0	0	0.9708737864077669	0.5107162768822324	CRTC2;PPP3CB;PFKL;PHKG2;SIK2
Peroxisome	4/83	0.6012622374752512	1.0	0	0	0.963855421686747	0.4903364861494962	PMVK;DHRS4L1;PEX11G;PEX14
PI3K-Akt signaling pathway	17/354	0.6033792093607264	1.0	0	0	0.96045197740113	0.48522937555551504	CRTC2;MAP2K2;FLT1;RPS6;PIK3CD;FGF3;CASP9;EFNA3;CCND2;CCND1;FGF18;ERBB2;GRB2;PKN2;HRAS;EPHA2;MCL1
Non-alcoholic fatty liver disease (NAFLD)	7/149	0.6208672064504345	1.0	0	0	0.9395973154362416	0.44784783988129884	COX8A;NDUFA11;NDUFB10;PIK3CD;NDUFB1;NDUFV2;ADIPOR2
Glycosaminoglycan degradation	1/19	0.6228154838888618	1.0	0	0	1.0526315789473684	0.4984262922061619	HYAL1
Pantothenate and CoA biosynthesis	1/19	0.6228154838888618	1.0	0	0	1.0526315789473684	0.4984262922061619	PANK4
Alzheimer disease	8/171	0.6268081564909365	1.0	0	0	0.935672514619883	0.4370664380599916	CASP9;COX8A;PPP3CB;NDUFA11;NDUFB10;NDUFB1;MAPT;NDUFV2
Influenza A	8/171	0.6268081564909365	1.0	0	0	0.935672514619883	0.4370664380599916	CASP9;HLA-DMA;MAP2K2;IRF3;STAT2;PIK3CD;EIF2AK4;TICAM1
Mitophagy	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	SP1;MFN2;HRAS
Shigellosis	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	ELMO3;BTRC;PFN1
Phagosome	7/152	0.6417021441357289	1.0	0	0	0.9210526315789472	0.4086075302976567	SCARB1;TUBB6;HLA-DMA;SFTPA1;ATP6V1E1;ATP6V1E2;FCGR2C
Natural killer cell mediated cytotoxicity	6/131	0.6446363815048852	1.0	0	0	0.916030534351145	0.4022004922971754	SHC2;PPP3CB;MAP2K2;PIK3CD;GRB2;HRAS
Pathways in cancer	25/530	0.6478598176654922	1.0	0	0	0.9433962264150944	0.40951031773194957	MAX;MGST3;PIK3CD;FGF3;CASP9;CCND2;CCND1;ERBB2;HRAS;FZD1;GSTM4;GSTM2;MAP2K2;MMP1;STAT2;PLEKHG5;DAPK3;F2;KIF7;ADCY9;SP1;FGF18;GRB2;BIRC2;GSTM5
Carbohydrate digestion and absorption	2/44	0.6532378269725155	1.0	0	0	0.9090909090909091	0.38710364483347576	ATP1A4;PIK3CD
Vasopressin-regulated water reabsorption	2/44	0.6532378269725155	1.0	0	0	0.9090909090909091	0.38710364483347576	ADCY9;AQP3
Long-term potentiation	3/67	0.657771791741192	1.0	0	0	0.8955223880597014	0.3751318467538853	PPP3CB;MAP2K2;HRAS
Arginine biosynthesis	1/21	0.6596258189717179	1.0	0	0	0.9523809523809523	0.3962690911289506	GLS2
Leukocyte transendothelial migration	5/112	0.6647517057733329	1.0	0	0	0.8928571428571428	0.3645907882365566	CLDN6;CLDN23;PIK3CD;BCAR1;MYL12B
Protein digestion and absorption	4/90	0.6647641861492688	1.0	0	0	0.8888888888888888	0.362953696452133	SLC8A3;COL7A1;ATP1A4;PGA5
Salivary secretion	4/90	0.6647641861492688	1.0	0	0	0.8888888888888888	0.362953696452133	ADCY9;ATP1A4;ATP2B4;AQP5
TGF-beta signaling pathway	4/90	0.6647641861492688	1.0	0	0	0.8888888888888888	0.362953696452133	TFDP1;SP1;BMP8A;SMAD9
Basal transcription factors	2/45	0.665369764985953	1.0	0	0	0.8888888888888888	0.3621443158089169	TAF13;GTF2F1
Glycosphingolipid biosynthesis	2/45	0.665369764985953	1.0	0	0	0.8888888888888888	0.3621443158089169	A3GALT2;ST6GALNAC6
Glycolysis / Gluconeogenesis	3/68	0.6676380497864279	1.0	0	0	0.8823529411764706	0.3564786122927678	PFKL;ALDOA;ENO3
Fc gamma R-mediated phagocytosis	4/91	0.6732482464251353	1.0	0	0	0.8791208791208791	0.34781639730574376	HCK;PIK3CD;AMPH;PIP5K1C
Terpenoid backbone biosynthesis	1/22	0.6766623505215513	1.0	0	0	0.9090909090909091	0.3550753401584873	PMVK
Alcoholism	8/180	0.683178744936179	1.0	0	0	0.8888888888888888	0.33866555380766933	HDAC5;SHC2;ADORA2B;HIST1H2BI;GRB2;HIST1H2BB;HIST2H3D;HRAS
Nucleotide excision repair	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	POLD4;POLD2
Sphingolipid metabolism	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	ACER2;ARSA
GnRH signaling pathway	4/93	0.6897669196744971	1.0	0	0	0.8602150537634409	0.3194851922842808	MAP2K2;ADCY9;GRB2;HRAS
Amino sugar and nucleotide sugar metabolism	2/48	0.6997136081858564	1.0	0	0	0.8333333333333333	0.29757013234898655	GMPPB;GALE
Intestinal immune network for IgA production	2/48	0.6997136081858564	1.0	0	0	0.8333333333333333	0.29757013234898655	HLA-DMA;MAP3K14
Vitamin digestion and absorption	1/24	0.7082222339049663	1.0	0	0	0.8333333333333333	0.28749778737100123	SCARB1
Malaria	2/49	0.7104927276749392	1.0	0	0	0.8163265306122448	0.2790176057147895	CR1;GYPB
Neurotrophin signaling pathway	5/119	0.7157855087234404	1.0	0	0	0.8403361344537815	0.2809871644732814	SHC2;MAP2K2;PIK3CD;GRB2;HRAS
Neuroactive ligand-receptor interaction	15/338	0.7191815436088637	1.0	0	0	0.8875739644970413	0.29258117622280166	THRB;NPY5R;PTAFR;C5AR1;PTH2R;F2;KISS1;P2RX7;MC1R;CYSLTR2;MTNR1B;ADORA2B;KISS1R;RLN3;NMUR1
Cholesterol metabolism	2/50	0.7209459791839935	1.0	0	0	0.7999999999999999	0.2617528554824198	SCARB1;PCSK9
Leishmaniasis	3/74	0.722455815470999	1.0	0	0	0.8108108108108109	0.2635937966943547	HLA-DMA;CR1;FCGR2C
PPAR signaling pathway	3/74	0.722455815470999	1.0	0	0	0.8108108108108109	0.2635937966943547	FABP5;MMP1;PLIN5
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/25	0.7228285803914951	1.0	0	0	0.7999999999999999	0.2596665438632063	PIGL
RNA transport	7/165	0.7238641717074015	1.0	0	0	0.8484848484848485	0.2741891619820413	NUP210L;THOC1;SAP18;SNORD3A;RPP25;EIF1B;EIF3A
cGMP-PKG signaling pathway	7/166	0.7296137574922477	1.0	0	0	0.8433734939759036	0.2658650469053982	SLC8A3;PPP3CB;MAP2K2;ADCY9;NPPA;ATP1A4;ATP2B4
Gastric acid secretion	3/75	0.7308710279969972	1.0	0	0	0.7999999999999999	0.2508146136696121	ADCY9;KCNJ10;ATP1A4
Amyotrophic lateral sclerosis (ALS)	2/51	0.7310789651903944	1.0	0	0	0.7843137254901961	0.24567356984329963	CASP9;PPP3CB
Cell adhesion molecules (CAMs)	6/145	0.7378766133412128	1.0	0	0	0.8275862068965517	0.25156854534135115	CLDN6;CD2;HLA-DMA;CLDN23;PTPRM;MPZL1
Platelet activation	5/124	0.7487088303457675	1.0	0	0	0.8064516129032258	0.23339122223979591	ADCY9;STIM1;PIK3CD;F2;MYL12B
Ribosome biogenesis in eukaryotes	4/101	0.7498448770134236	1.0	0	0	0.792079207920792	0.22803083128155077	RNA5S12;IMP3;SNORD3A;RPP25
Biosynthesis of unsaturated fatty acids	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	ACOT7
Fatty acid elongation	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	ACOT7
Glycosaminoglycan biosynthesis	2/53	0.7504077852742062	1.0	0	0	0.7547169811320754	0.21670830680118947	B3GAT3;XYLT1
Synaptic vesicle cycle	3/78	0.7549122409335416	1.0	0	0	0.7692307692307693	0.2162721335871487	AP2S1;ATP6V1E1;ATP6V1E2
Retrograde endocannabinoid signaling	6/148	0.7553912967971983	1.0	0	0	0.8108108108108109	0.22744815412465288	ADCY9;NDUFA11;NDUFB10;NDUFB1;NDUFV2;DAGLB
Longevity regulating pathway	4/102	0.7566871822236416	1.0	0	0	0.7843137254901961	0.21867085840898748	ADCY9;PIK3CD;ADIPOR2;HRAS
Fanconi anemia pathway	2/54	0.7596159436572443	1.0	0	0	0.7407407407407407	0.2036609709042825	BLM;FANCA
Phototransduction	1/28	0.7624087879510514	1.0	0	0	0.7142857142857142	0.19376600001083732	GRK1
Legionellosis	2/55	0.7685284162153218	1.0	0	0	0.7272727272727272	0.1914747203489268	CASP9;CR1
Th17 cell differentiation	4/107	0.7887401751709202	1.0	0	0	0.747663551401869	0.1774342589951246	PPP3CB;HLA-DMA;IL17D;IL27RA
NOD-like receptor signaling pathway	7/178	0.7921477736375266	1.0	0	0	0.7865168539325842	0.1832641856039621	P2RX7;NLRP6;IRF3;STAT2;MFN2;TICAM1;BIRC2
Proteoglycans in cancer	8/201	0.7925273344506804	1.0	0	0	0.7960199004975124	0.18509714022296506	FZD1;MAP2K2;CCND1;RPS6;ERBB2;PIK3CD;GRB2;HRAS
Asthma	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	HLA-DMA
Circadian rhythm	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	BTRC
Systemic lupus erythematosus	5/133	0.8006749703651704	1.0	0	0	0.7518796992481203	0.1671430030702634	HLA-DMA;C1S;HIST1H2BI;HIST1H2BB;HIST2H3D
Herpes simplex virus 1 infection	21/492	0.8027195498327405	1.0	0	0	0.8536585365853658	0.18759136016352254	ZNF595;ZNF382;ZNF140;ZNF705E;ZNF160;STAT2;PIK3CD;EIF2AK4;TICAM1;CASP9;HLA-DMA;ZNF519;IRF3;ZNF557;ZNF700;ZNF688;ZNF555;ZNF554;ZNF124;BIRC2;ZNF761
TNF signaling pathway	4/110	0.8062945339593786	1.0	0	0	0.7272727272727272	0.1565863101665403	MLKL;PIK3CD;MAP3K14;BIRC2
MicroRNAs in cancer	12/299	0.8206716096774825	1.0	0	0	0.802675585284281	0.1586345721141662	EFNA3;CCND2;MAP2K2;CCND1;GLS2;ERBB2;MIR520B;IGF2BP1;MIR200B;GRB2;HRAS;MCL1
Toxoplasmosis	4/113	0.8226434279131911	1.0	0	0	0.7079646017699115	0.13821765033879096	CASP9;HLA-DMA;ALOX5;BIRC2
SNARE interactions in vesicular transport	1/34	0.8254324369271197	1.0	0	0	0.588235294117647	0.11285168470716885	VAMP1
Basal cell carcinoma	2/63	0.8299778549215587	1.0	0	0	0.6349206349206349	0.1183214345173536	FZD1;KIF7
Fluid shear stress and atherosclerosis	5/139	0.8303434515247903	1.0	0	0	0.7194244604316546	0.13375242213240954	GSTM4;GSTM2;MGST3;PIK3CD;GSTM5
Prion diseases	1/35	0.8341755971925006	1.0	0	0	0.5714285714285714	0.103606486053202	MAP2K2
cAMP signaling pathway	8/212	0.8372766048951447	1.0	0	0	0.7547169811320754	0.1340383330476813	ADCY9;MAP2K2;NPPA;ATP1A4;ATP2B4;PIK3CD;ARAP3;CNGA4
Protein processing in endoplasmic reticulum	6/165	0.8385956609296656	1.0	0	0	0.7272727272727272	0.12801935886721602	ERO1A;PPP1R15A;LMAN1;HYOU1;EIF2AK4;UBE2J2
mRNA surveillance pathway	3/91	0.8396768561291149	1.0	0	0	0.6593406593406593	0.11521197114942941	SMG1;SSU72;SAP18
Inflammatory bowel disease (IBD)	2/65	0.8428493095437481	1.0	0	0	0.6153846153846154	0.10521051812214251	HLA-DMA;IL18RAP
Aminoacyl-tRNA biosynthesis	2/66	0.8489478345965421	1.0	0	0	0.6060606060606061	0.09924699267132996	YARS;PARS2
IL-17 signaling pathway	3/93	0.8501804853980194	1.0	0	0	0.6451612903225806	0.10471394598415903	CCL7;MMP1;IL17D
African trypanosomiasis	1/37	0.8503713249208762	1.0	0	0	0.5405405405405406	0.08761198488762709	NPPA
Primary immunodeficiency	1/37	0.8503713249208762	1.0	0	0	0.5405405405405406	0.08761198488762709	IGLL1
Sphingolipid signaling pathway	4/119	0.851921877903696	1.0	0	0	0.6722689075630252	0.10773811694664917	ACER2;MAP2K2;PIK3CD;HRAS
Retinol metabolism	2/67	0.8548301611907013	1.0	0	0	0.5970149253731343	0.0936432666623936	RDH16;DHRS4L1
Allograft rejection	1/38	0.8578665401729517	1.0	0	0	0.5263157894736842	0.08068775746154062	HLA-DMA
Renin secretion	2/69	0.8659715129706728	1.0	0	0	0.5797101449275363	0.08342218313842696	PPP3CB;NPPA
Lysosome	4/123	0.8690779693984211	1.0	0	0	0.6504065040650406	0.091266624138801	ARSA;HYAL1;CTSK;AP3D1
Circadian entrainment	3/97	0.8694002721574682	1.0	0	0	0.6185567010309279	0.08656802931150201	RYR1;ADCY9;MTNR1B
RIG-I-like receptor signaling pathway	2/70	0.8712429450339811	1.0	0	0	0.5714285714285714	0.0787625225498065	IRF3;ISG15
Ferroptosis	1/40	0.8717504251826977	1.0	0	0	0.5	0.06862605284591321	GPX4
Cell cycle	4/124	0.8730902649815165	1.0	0	0	0.6451612903225806	0.08755892398339275	CCND2;TFDP1;CCND1;SFN
Cytokine-cytokine receptor interaction	11/294	0.8744398369200312	1.0	0	0	0.7482993197278911	0.10040065470018435	IL20;IL18RAP;CCL7;CLCF1;CCL4;BMP8A;ACKR3;LTB;CCL18;IL17D;IL27RA
Phosphatidylinositol signaling system	3/99	0.8781684208695373	1.0	0	0	0.6060606060606061	0.07873750329026426	IMPA2;PIK3CD;PIP5K1C
Progesterone-mediated oocyte maturation	3/99	0.8781684208695373	1.0	0	0	0.6060606060606061	0.07873750329026426	ADCY9;PIK3CD;KIF22
Graft-versus-host disease	1/41	0.878175666331951	1.0	0	0	0.4878048780487805	0.0633700633222169	HLA-DMA
AGE-RAGE signaling pathway in diabetic complications	3/100	0.8823533306415342	1.0	0	0	0.6	0.07509762093621879	CCND1;PIK3CD;HRAS
Tuberculosis	6/179	0.8885227601225182	1.0	0	0	0.6703910614525139	0.07923688181265258	CASP9;PPP3CB;HLA-DMA;CR1;NFYB;FCGR2C
Type I diabetes mellitus	1/43	0.8900774268754144	1.0	0	0	0.46511627906976744	0.05416131327939396	HLA-DMA
Thyroid hormone synthesis	2/74	0.8904734986911036	1.0	0	0	0.5405405405405406	0.06270374958254536	ADCY9;ATP1A4
Chagas disease (American trypanosomiasis)	3/103	0.8941493670111881	1.0	0	0	0.5825242718446602	0.06517423722567385	GNAL;PIK3CD;TICAM1
Fatty acid degradation	1/44	0.8955853061573006	1.0	0	0	0.45454545454545453	0.05012627322480098	ACADVL
Antigen processing and presentation	2/77	0.9031081450221422	1.0	0	0	0.5194805194805194	0.05294180301649679	HLA-DMA;NFYB
Type II diabetes mellitus	1/46	0.9057876758651223	1.0	0	0	0.43478260869565216	0.04302189293649987	PIK3CD
Cardiac muscle contraction	2/78	0.9070080241695482	1.0	0	0	0.5128205128205128	0.0500533240880421	COX8A;ATP1A4
Human immunodeficiency virus 1 infection	7/212	0.9102489016760925	1.0	0	0	0.660377358490566	0.06210003677512062	CASP9;PPP3CB;MAP2K2;IRF3;PIK3CD;BTRC;HRAS
Cysteine and methionine metabolism	1/47	0.9105090567783704	1.0	0	0	0.42553191489361697	0.03989422673431822	CDO1
Valine, leucine and isoleucine degradation	1/48	0.914994048233663	1.0	0	0	0.41666666666666663	0.03701571599601437	OXCT2
N-Glycan biosynthesis	1/50	0.9233015685863551	1.0	0	0	0.39999999999999997	0.03191974852547144	ALG14
Cholinergic synapse	3/112	0.9234195962447295	1.0	0	0	0.5357142857142857	0.04268118605193645	ADCY9;PIK3CD;HRAS
Glutamatergic synapse	3/114	0.9288257077278166	1.0	0	0	0.5263157894736842	0.038860089762793495	PPP3CB;ADCY9;GLS2
Insulin secretion	2/86	0.9333063042418757	1.0	0	0	0.46511627906976744	0.032103177510297835	ADCY9;ATP1A4
Autoimmune thyroid disease	1/53	0.9342669389173686	1.0	0	0	0.3773584905660377	0.02565776594269266	HLA-DMA
Adrenergic signaling in cardiomyocytes	4/145	0.9358455515330878	1.0	0	0	0.5517241379310345	0.03658197250531409	ADCY9;ATP1A4;ATP2B4;SCN4B
Pathogenic Escherichia coli infection	1/55	0.9406924613791231	1.0	0	0	0.3636363636363636	0.022232368682920493	TUBB6
GABAergic synapse	2/89	0.9412159961600209	1.0	0	0	0.449438202247191	0.02722814686661418	ADCY9;GLS2
Dilated cardiomyopathy (DCM)	2/91	0.9459848142593618	1.0	0	0	0.43956043956043955	0.024408247313871943	MYBPC3;ADCY9
Th1 and Th2 cell differentiation	2/92	0.9482287784921883	1.0	0	0	0.43478260869565216	0.02311281666022285	PPP3CB;HLA-DMA
Oocyte meiosis	3/125	0.9527728742359944	1.0	0	0	0.48	0.023221790818524435	PPP3CB;ADCY9;BTRC
Amoebiasis	2/96	0.9563462737985303	1.0	0	0	0.41666666666666663	0.018598008511252703	GNAL;PIK3CD
Glycerolipid metabolism	1/61	0.956442628953957	1.0	0	0	0.32786885245901637	0.014601466257298934	LPIN2
Purine metabolism	3/129	0.9594354431483884	1.0	0	0	0.46511627906976744	0.01926058026089093	ENTPD1;ADCY9;CANT1
Inflammatory mediator regulation of TRP channels	2/100	0.9632369873558141	1.0	0	0	0.39999999999999997	0.014982321868347009	ADCY9;PIK3CD
Necroptosis	4/162	0.9643248581685346	1.0	0	0	0.49382716049382713	0.01793928461161327	MLKL;STAT2;TICAM1;BIRC2
Spliceosome	3/134	0.9665252718637258	1.0	0	0	0.4477611940298507	0.015245298295546113	CCDC12;THOC1;DHX15
Amphetamine addiction	1/68	0.9696175495526317	1.0	0	0	0.2941176470588235	0.009074577660222398	PPP3CB
Ubiquitin mediated proteolysis	3/137	0.9702000312158441	1.0	0	0	0.43795620437956206	0.013249493867024583	BTRC;UBE2J2;BIRC2
Adipocytokine signaling pathway	1/69	0.9711417402987961	1.0	0	0	0.2898550724637681	0.00848778197469868	ADIPOR2
Parathyroid hormone synthesis, secretion and action	2/106	0.9716500119085215	1.0	0	0	0.3773584905660377	0.010852682798281577	ADCY9;SP1
Insulin resistance	2/108	0.9740164985643297	1.0	0	0	0.37037037037037035	0.009750754261227252	CRTC2;PIK3CD
Serotonergic synapse	2/113	0.9791273621981581	1.0	0	0	0.35398230088495575	0.007466743623819164	ALOX5;HRAS
ECM-receptor interaction	1/82	0.9852227825319085	1.0	0	0	0.24390243902439024	0.003631094688901337	SV2B
Taste transduction	1/83	0.9859645609779344	1.0	0	0	0.24096385542168675	0.0034059921056594548	TAS2R7
Hypertrophic cardiomyopathy (HCM)	1/85	0.987338361755133	1.0	0	0	0.23529411764705882	0.0029982305654579823	MYBPC3
Dopaminergic synapse	2/131	0.9906225720039081	1.0	0	0	0.30534351145038163	0.002876846685028434	PPP3CB;GNAL
Morphine addiction	1/91	0.9907047643496917	1.0	0	0	0.21978021978021978	0.002052462844095697	ADCY9
Olfactory transduction	10/444	0.9990198992607794	1.0	0	0	0.4504504504504504	4.4170331171550345E-4	SLC8A3;OR8B12;OR4F15;GNAL;OR5AN1;CNGA4;OR4D6;OR52K1;OR5B17;OR10A6
